FDA approved two generic rivals to Reckitt Benckiser's heroin addiction drug Suboxone. The U.K.-based company had petitioned the agency to block the copycat versions on packaging grounds. Report
FDA approved two generic rivals to Reckitt Benckiser's heroin addiction drug Suboxone. The U.K.-based company had petitioned the agency to block the copycat versions on packaging grounds. Report